Anemia is a prevalent complication in patients with CRF and is mainly mediated by increased toxicity, inadequate erythropoietin (EPO) production, inflammation, nutritional deficiencies, and oxidative stress (2). This evidence concerns the gene EPO and anemia (phenotype).